Skip to main content
Caplight Logo









OtusOphta Ltd.

OtusOphta Ltd.

Private
TampereHealthcare & Life Scienceshttps://www.otusophta.com/

Last Round

Grant

Oct 9, 2024

Company Overview

OtusOphta Ltd. is a biotechnology company developing a treatment for dry eye disease based on its RevEye technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

dry eye disease treatmentevaporative dry eye diseasetear film restorationDEDlipid-based therapeuticpreclinical biotechearly-stage biotechuniversity spinoutacademic spinoutophthalmology therapeuticclinical trialspharma licensingdrug discoverytear film lipid layer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OtusOphta Ltd. Comparables

Compare OtusOphta Ltd. with similar companies based on industry and business-model similarity.

OtusOphta Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
26 Therapeutics Inc.
79%
Stuart Therapeutics, Inc.
78%
Novaliq
73%

OtusOphta Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 9, 2024
SeedOct 9, 2024

OtusOphta Ltd. Investors

Notable investors and investment history

OtusOphta Ltd. investors
InvestorRounds
Helsinki University FundsSeed
Business FinlandGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 9, 2024

    Seed round led by Helsinki University Funds.

  • Oct 9, 2024

    Received grant funding from Business Finland.

OtusOphta Ltd. Filings

Explore SEC and related filing metadata, where available.

OtusOphta Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about OtusOphta Ltd.'s valuation, stock price, and market status.

Is OtusOphta Ltd. a public or private company?

OtusOphta Ltd. is a private company.

What is the current stock price of OtusOphta Ltd.?

OtusOphta Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is OtusOphta Ltd. worth (valuation)?

Valuation information for OtusOphta Ltd. is not publicly available.

Can I buy OtusOphta Ltd. stock?

OtusOphta Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was OtusOphta Ltd.'s last funding round?

OtusOphta Ltd.'s most recent funding round was Grant on October 9, 2024.

Who are the main investors in OtusOphta Ltd.?

Key investors in OtusOphta Ltd. include Helsinki University Funds.

Will OtusOphta Ltd. IPO soon?

No public IPO plans have been announced for OtusOphta Ltd..

How can I track OtusOphta Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OtusOphta Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTampere
Year Founded2024
Last FundingOct 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?